OncLive® On Air

OncLive® On Air

Por: OncLive® On Air
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

500 episodios disponibles

Latest episodes of the podcast OncLive® On Air

Mostrando página 16 de 25

S9 Ep35: Hasanuma Highlights the Benefits of Building Authentic Connections Through Mentorship 19/10/2023
S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia 16/10/2023
S9 Ep33: Gutierrez and Leslie Discuss Recent Efforts and Future Advances in CAR T-Cell Therapy 12/10/2023
S9 Ep32: Expert Insights on the United States Chemotherapy Shortage 09/10/2023
S9 Ep31: FDA Approval Insights: First-Line Luspatercept for Anemia in Lower-Risk MDS 05/10/2023
S9 Ep30: Richardson Reviews Findings and Future Directions With Mezigdomide Plus Dexamethasone in R/R Myeloma 02/10/2023
S9 Ep29: Garcia-Manero and Zeidan Highlight Key Implications of the COMMANDS Trial in Lower-Risk MDS 28/09/2023
S9 Ep28: FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma 21/09/2023
S9 Ep27: Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST 18/09/2023
S9 Ep26: Chuong Discusses the Importance of MRI-Guided Radiotherapy in Cancer 14/09/2023
S9 Ep25: Fonkoua Sheds Light on Liver Cancer Clinical Trial Disparities 11/09/2023
S9 Ep24: FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma 07/09/2023
S9 Ep23: Usmani Highlights the Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma 04/09/2023
S9 Ep22: Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC 31/08/2023
S9 Ep21: FDA Approval Insights: Dostarlimab Plus Chemotherapy in dMMR/MSI-H Advanced Endometrial Cancer 28/08/2023
S9 Ep20: FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML 21/08/2023
S9 Ep19: Trent Breaks Down Mutation Testing and ctDNA Monitoring in GIST 17/08/2023
S9 Ep18: Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML 14/08/2023
S9 Ep17: Sanai Spotlights Meningioma Symptoms, Treatment Options, and Research Needs 10/08/2023
S9 Ep16: Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers 07/08/2023
« Primera ‹ Anterior 1 ... 14 15 16 17 18 ... 25 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA